Christopher Seiter
No más puestos en curso
Perfil
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Antiguos cargos conocidos de Christopher Seiter.
| Empresas | Cargo | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Director Financiero/CFO | 02/04/2021 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Director Financiero/CFO | - |
Formación de Christopher Seiter.
| Rochester Christian University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
| Bank of America Merrill Lynch (New York) |
- Bolsa de valores
- Insiders
- Christopher Seiter
